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The 8th annual Corporate Council
Meeting took place September 21 and
22 at the Royal Palms Resort in Phoenix,
Arizona. Fifteen (15) representatives
from our pharmaceutical members
were given the opportunity to meet
face-to-face with past and current
ASBMT leadership in an informal, col-
legial environment. Invited speakers
talked on a range of subjects, from the
relationship between academia and
the corporate world, to cord blood ex-
pansion, microtransplantation, chronic
GVHD and more.
Carl June to Present E. Donnall
Thomas Lecture
Carl H. June MD, of the Abramson
Cancer Center, will present the 18th
annual E. Donnall Thomas Lecture at the
2015 BMT Tandem Meetings, Feb. 11-15
in San Diego.
His presentation will be on Friday,
Feb. 13.
ASBMT Awards
During the 2015 BMT Tandem
Meetings, ASBMT will present the
annual Lifetime Achievement Award to
Daniel Weisdorf, MD, and will present
the Public Service Award toUniversity of
Miami President Donna E. Shalala, PhD.1083-8791/$ – see front matter
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Completed
ASBMT held their Clinical Research
Training Course in Park City, Utah from
July 9-14 and this 8th annual eventwas a
great success.11 faculty,12 scholars and1
ASBMT staff member were on-site at the
Hotel Park City from July 9 to July 14 for 5
full days of educational sessions. The
ASBMT Board of Directors created the
course in 2006 because of concerns that
clinical fellowship programs don’t ade-
quately cover the principles of research
and how to take ﬁndings from the labo-
ratory to the clinic. The coursehelps close
the gap by addressing those deﬁciencies
and includes formal presentations, ex-
tensive follow-up dialogue and small-
group discussion. Faculty presentations
cover topics such as Research subject
eligibility and recruitment; Clinical trial
design; Biostatistics; Data management
and quality control; Study endpoints;
Late effects and quality of life; Clinical
pharmacology, including polypharmacy
and drug interactions; and more.
3RD Annual BMT Winter Workshop
On the eve of the ASH Annual
Meeting, leaders in Bone Marrow Trans-
plantation (BMT) from all over the world
will review their latest andmost exciting
new ﬁndings in a dynamic workshop.The “BMT Winter Workshop” was
created by co-chairs Dr. Marcel van den
Brink, Head of the Division of the
Hematologic Oncology at Memorial
Sloan Kettering Cancer Center and Dr.
Edmund K. Waller, Director of Emory
University’s BoneMarrow and Stem Cell
Transplant Center. Since its inception in
2012, the annual workshop has pro-
vided a catalytic forum that has helped
facilitate the application of new tech-
nologies to old and new BMT chal-
lenges. The program features fast-paced
talks by 18 experts, including out-
standing luminaries in the BMT ﬁeld,
addressing recent unpublished data on
high-impact clinical and pre-clinical
studies.
The 3rd Annual BMT Winter Work-
shop will be hosted jointly by UCSF and
Stanford under the direction of Drs.
Lloyd Damon and David Miklos, re-
spectively. This workshop offers an
opportunity to learn more about the
current status of research related to
HSCT, to share your research, and to
discuss opportunities to work together.
Building on the tradition of connecting
innovative researchers, this year’s cut-
ting edge workshop will continue to
accelerate translational research in the
BMT ﬁeld.
